Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$373.53 - $434.12 $1.16 Million - $1.35 Million
-3,117 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$396.76 - $455.92 $26,582 - $30,546
-67 Reduced 2.1%
3,117 $1.29 Million
Q2 2021

Aug 11, 2021

BUY
$372.36 - $412.07 $42,821 - $47,388
115 Added 3.75%
3,184 $1.26 Million
Q1 2021

May 14, 2021

BUY
$357.26 - $392.57 $1.1 Million - $1.2 Million
3,069 New
3,069 $1.18 Million
Q4 2020

Feb 12, 2021

SELL
$319.05 - $363.32 $864,625 - $984,597
-2,710 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$280.08 - $347.78 $3,360 - $4,173
12 Added 0.44%
2,710 $904,000
Q2 2020

Aug 12, 2020

BUY
$270.93 - $320.3 $5,689 - $6,726
21 Added 0.78%
2,698 $730,000
Q1 2020

May 11, 2020

BUY
$243.44 - $359.98 $51,609 - $76,315
212 Added 8.6%
2,677 $737,000
Q4 2019

Feb 07, 2020

BUY
$281.18 - $322.05 $57,641 - $66,020
205 Added 9.07%
2,465 $791,000
Q3 2019

Nov 04, 2019

BUY
$294.25 - $341.49 $90,040 - $104,495
306 Added 15.66%
2,260 $671,000
Q2 2019

Aug 05, 2019

BUY
$279.29 - $336.89 $53,065 - $64,009
190 Added 10.77%
1,954 $658,000
Q1 2019

May 01, 2019

SELL
$246.18 - $297.25 $291,230 - $351,646
-1,183 Reduced 40.14%
1,764 $522,000
Q4 2018

Feb 11, 2019

BUY
$232.7 - $281.66 $127,054 - $153,786
546 Added 22.74%
2,947 $750,000
Q3 2018

Nov 08, 2018

BUY
$236.3 - $277.15 $89,557 - $105,039
379 Added 18.74%
2,401 $665,000
Q2 2018

Aug 07, 2018

SELL
$217.98 - $237.23 $3.27 Million - $3.56 Million
-14,992 Reduced 88.12%
2,022 $476,000
Q1 2018

May 09, 2018

SELL
$218.74 - $251.43 $184,616 - $212,206
-844 Reduced 4.73%
17,014 $3.89 Million
Q4 2017

Feb 09, 2018

SELL
$217.88 - $244.43 $41.5 Million - $46.6 Million
-190,689 Reduced 91.44%
17,858 $3.91 Million
Q3 2017

Nov 09, 2017

BUY
$231.6 - $253.39 $48.3 Million - $52.8 Million
208,547
208,547 $50.2 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.